Sojournix
Latest round
- Series C
Last raised
- Jan 2019
Total raised
- $46M
Investors
- 5
About Sojournix
Sojournix Inc.Founded in 2016 and headquartered in Waltham, US, Sojournix Inc. specializes in creating novel treatment solutions for neurological conditions.Sojournix Inc. develops proprietary therapeutics aimed at addressing unmet medical needs in neurological treatment.Sojournix Inc. operates under a revenue model based on successful product development and potential partnerships with pharmaceutical entities.Sojournix Inc. The company plans to launch new drug candidates in 2022, targeting further clinical trials to enhance treatment offerings. Expansion efforts are focused on entering key international markets, particularly in Europe and Asia, by 2023, thereby broadening its reach and impact in the global biotech arena.
Who invested in Sojournix
5 investors across 3 rounds
See all investors in Sojournix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sojournix
Who invested in Sojournix?
Sojournix has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sojournix raised?
Sojournix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sojournix last raise money?
Sojournix's most recent round on record is a Series C, in Jan 2019.
What does Sojournix do?
Sojournix is a pharmaceuticals company.
Where is Sojournix headquartered?
Sojournix is headquartered in Waltham, US.
Which VCs invest in companies like Sojournix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sojournix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Sojournix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.